Brain Cancer Clinical Trials

Showing 881-900 of 1,466 trials

In Vivo Succinate Detection After External Beam Radiation Therapy in SDHx- Paragangliomas

NCT04583384

Qualitative and quantitative biomarker of response to radiotherapy is needed in paragangliomas. We aim at assessing the added value of 1H-SRM for the evaluation of early response to EBR therapy in patients with cervical SDHx PGL.

Paraganglioma of Head and Neck

Assistance Publique - Hôpitaux de Paris32 participantsStarted Oct 2020

Paris, France • Paris, France • Paris, France

TERMINATED

Medical Treatment Decision Making Using Adaptive Conjoint Analysis

NCT02608307

In the setting of progressive or recurrent cancer, adolescent and young adult (AYA) patients, parents, and healthcare providers (HCP) are faced with multiple therapeutic options. Each treatment option has a unique risk/benefit ratio, resulting in a need to trade one desirable outcome for another or accept acute toxicities and treatment-related morbidity to increase the chance of survival. Adding to the complexity of this decision, stake holders characterize and value the risk/benefit ratios differently. This study seeks to learn what things are important to an adolescent or young adult with cancer, parents, and health care providers when making decisions about their treatment choices. PRIMARY OBJECTIVE: To quantify the relative importance of various factors believed to be important to adolescent and young adult patients with cancer, parents, and health care providers when choosing between treatment options in the hypothetical situation of progressive or refractory disease.

CancerBrain TumorSolid Tumor+2 more

St. Jude Children's Research Hospital25 participantsStarted Feb 2016

Memphis, Tennessee, United States

UNKNOWNNA

Strategic Intervention on Preserving Motor Function During Awake Craniotomy

NCT05143788

This study aims to compare the motor functions after traditional or a new surgical plan during awake glioma resection surgery.

Glioma

Beijing Neurosurgical Institute60 participantsStarted Dec 2021

In Vivo Succinate Detection After External Beam Radiation Therapy in SDHx- Paragangliomas

Medical Treatment Decision Making Using Adaptive Conjoint Analysis

Strategic Intervention on Preserving Motor Function During Awake Craniotomy

Related Searches

Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma

Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab

Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over

A Prospective Phase II Efficacy and Safety Study of Anlotinib in Metastatic or Locally Advanced Pheochromocytoma/ Paraganglioma : Open-label Single-arm, Exploratory Trial

Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)

Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients

Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma

Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients

5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme

Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas

Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme

The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma